The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity
Abstract
Summary: Tissue damage occurs often in the life of mammals and is usually repaired. Dying cells are swiftly phagocytosed, but before disappearing, they alert surrounding cells to activate homeostatic programs. They release signals that recruit inflammatory cells to the site of injury, promote cell migration and cell division to replace dead cells, and activate the immune system in anticipation of microbial invasion. Many of these events involve high‐mobility group box 1 protein (HMGB1), a nuclear protein that is released passively when necrotic cells lose the integrity of their membranes. HMGB1 behaves as a trigger of inflammation, attracting inflammatory cells, and of tissue repair, recruiting stem cells and promoting their proliferation. Moreover, HMGB1 activates dendritic cells (DCs) and promotes their functional maturation and their response to lymph node chemokines. Activated leukocytes actively secrete HMGB1 in the microenvironment. Thus, HMGB1 acts in an autocrine/paracrine fashion and sustains long‐term repair and defense programs. DCs secrete HMGB1 several hours after contact with the first maturation stimulus; HMGB1 secretion is critical for their ability to reach the lymph nodes, to sustain the proliferation of antigen‐specific T cells, to prevent their activation‐dependent apoptosis, and to promote their polarization towards a T‐helper 1 phenotype. These immune responses will also be directed against self‐antigens that DCs process at the time of injury and can lead to autoimmunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, PRR present on or within DC include a group of signaling receptors that stimulate the post uptake reactions (including toll-like receptors, NOD-like receptors, and RIG1-like helicases)52,107.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [52]
In the citing paper
“Similarly, HSPs exposed on or released by tumor cells may act on multiple receptors including CD91, scavenger receptors, TLR2 and TLR4 52.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [52]
In the citing paper
“Thus, HMGB1 may act on the receptor for advanced glycated endproducts (RAGEs) and possibly the toll-like receptors (TLRs) including TLR2 and TLR4 51,52, although the latter are controversial 53.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [52]
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
Self-citationHMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Self-citationChromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette-Zlatanova, B. C., Shlomchik, M. J., & Marshak‐Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,929
Park, J. S., Svetkauskaite, D., He, Q., Kim, J., Strassheim, D., Ishizaka, A., & Abraham, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,582
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252
Self-citation
Research works printed but not linked: 1
- Fiuza C, 2002, Inflammatory promoting activity of HMGB1 on human microvascular endothelial cells, Blood, 27, 2652
Cited by
Sorted by citations
Items 101–200 of 600
The immunogenicity of tumor cell death
Kepp, O., Tesnière, A., Zitvogel, L., & Kroemer, G. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32831bc375 · Cited by 124
HMGB1 Protein Binds to Influenza Virus Nucleoprotein and Promotes Viral Replication
Moisy, D., Avilov, S., Jacob, Y., Laoide, B. M., Ge, X., Baudin, F., Naffakh, N., & Jestin, J. (2012) · Journal of Virology · doi:10.1128/jvi.00789-12 · Cited by 116
eIF2α phosphorylation as a biomarker of immunogenic cell death
Kepp, O., Semeraro, M., Pedro, J. M. B., Bloy, N., Buqué, A., Huang, X., Zhou, H., Senovilla, L., Kroemer, G., & Galluzzi, L. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.004 · Cited by 118
Vitali, R., Stronati, L., Negroni, A., Nardo, G. D., Pierdomenico, M., Giudice, E. D., Rossi, P., & Cucchiara, S. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.231 · Cited by 117
Fu, L., Liu, K., Wake, H., Teshigawara, K., Yoshino, T., Takahashi, H. K., Mori, S., & Nishibori, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01325-y · Cited by 115
Han, R., Liu, Z., Sun, N., Liu, S., Li, L., Shen, Y., Xiu, J., & Xu, Q. (2018) · Aging and Disease · doi:10.14336/ad.2018.0707 · Cited by 116
Romero, R. J., Chaiworapongsa, T., Savasan, Z. A., Hussein, Y., Dong, Z., Kusanovic, J. P., Kim, C. J., & Hassan, S. S. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.599083 · Cited by 112
Encinas, P., Rodríguez-Milla, M. Á., Novoa, B., Estepa, A., Figueras, A. J., & Coll, J. M. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-518 · Cited by 109
Li, J., Yao, Y.-M., & Tian, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701163 · Cited by 111
The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
Guo, R., Duan, J., Pan, S., Cheng, F., Qiao, Y., Feng, Q., Liu, D., & Liu, Z. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05969-9 · Cited by 108
Lian, Y., Gong, H., Wu, T., Su, W., Zhang, Y., Yang, Y., Wei, P., Zhang, T., Zhou, J., Jiang, C., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.017 · Cited by 105
Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders
Paudel, Y. N., Angelopoulou, E., Semple, B. D., Piperi, C., Othman, I., & Shaikh, M. F. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00640 · Cited by 107
Au, A. K., Aneja, R. K., Bell, M. J., Bayır, H., Feldman, K., Adelson, P. D., Fink, E. L., Kochanek, P. M., & Clark, R. S. B. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.2171 · Cited by 105
High‐Mobility Group Box‐1 and Liver Disease
Gaskell, H., Ge, X., & Nieto, N. (2018) · Hepatology Communications · doi:10.1002/hep4.1223 · Cited by 104
High-mobility group box 1 (HMGB1) as a master regulator of innate immunity
Castiglioni, A., Canti, V., Rovere, P. Q., & Manfredi, A. A. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1033-1 · Cited by 104
Self-citationReeves, R. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.09.015 · Cited by 110
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target
VanPatten, S., & Al‐Abed, Y. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01136 · Cited by 103
Neuroinflammation in Post-Traumatic Epilepsy: Pathophysiology and Tractable Therapeutic Targets
Sharma, R., Leung, W. L., Zamani, A., O'Brien, T. J., Casillas-Espinosa, P. M., & Semple, B. D. (2019) · Brain Sciences · doi:10.3390/brainsci9110318 · Cited by 104
Nanoparticles-mediated emerging approaches for effective treatment of ischemic stroke
He, W., Zhang, Z., & Sha, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121111 · Cited by 102
Microenvironmental influences of apoptosis in vivo and in vitro
Gregory, C. D., & Pound, J. D. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0485-9 · Cited by 103
Imanguli, M. M., Swaim, W. D., League, S. C., Gress, R. E., Pavletic, S. Z., & Hakim, F. T. (2009) · Blood · doi:10.1182/blood-2008-07-168351 · Cited by 103
Hayakawa, K., Mishima, K., Irie, K., Hazekawa, M., Mishima, S., Fujioka, M., Orito, K., Egashira, N., Katsurabayashi, S., Takasaki, K., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.040 · Cited by 105
Wang, K., Yu, G., Zhang, Z.-Y., Huang, Q., & Dong, X. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.07.002 · Cited by 99
Schildkopf, P., Ott, O. J., Frey, B., Wadepohl, M., Sauer, R., Fietkau, R., & Gaipl, U. S. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791959774 · Cited by 99
Jeong, W., Yang, C. E., Roh, T. S., Kim, J. H., Lee, J. H., & Lee, W. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081698 · Cited by 97
The immunosuppressive side of PDT
Mróz, P., & Hamblin, M. R. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c0pp00345j · Cited by 99
AGE–RAGE stress: a changing landscape in pathology and treatment of Alzheimer’s disease
Prasad, K. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03553-4 · Cited by 97
Shi, W., Feng, W., Li, S., Cui, Y., Liu, S., Jiang, H., Liu, Y., & Zhang, H. (2023) · ACS Nano · doi:10.1021/acsnano.3c00901 · Cited by 94
Zhang, K., Yang, C., Cheng, C., Shi, C., Sun, M., Hu, H., Shi, T., Chen, X., He, X., Zheng, X., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c04300 · Cited by 96
IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid
Yabu, M., Shime, H., Hara, H., Saito, T., Matsumoto, M., Seya, T., Akazawa, T., & Inoue, N. (2010) · International Immunology · doi:10.1093/intimm/dxq455 · Cited by 98
Zhang, J., Wu, Y., Weng, Z., Zhou, T., Feng, T., & Lin, Y. (2014) · Brain Research · doi:10.1016/j.brainres.2014.07.002 · Cited by 94
Kim, S.-W., Lim, C., Kim, J., Shin, J., Lee, S., Lee, M., & Lee, J.-K. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9231-x · Cited by 94
Paudel, Y. N., Semple, B. D., Jones, N. C., Othman, I., & Shaikh, M. F. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14663 · Cited by 92
Kruse, K., Janko, C., Urbonaviciute, V., Mierke, C. T., Winkler, T., Voll, R. E., Schett, G. A., Munoz, L. E., & i, M. H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0478-8 · Cited by 94
Riuzzi, F., Sorci, G., Sagheddu, R., & Donato, R. (2012) · Journal of Cell Science · doi:10.1242/jcs.092163 · Cited by 91
DAMPs and sterile inflammation in drug hepatotoxicity
Yang, R., & Tonnesseen, T. I. (2018) · Hepatology International · doi:10.1007/s12072-018-9911-9 · Cited by 92
Zandarashvili, L., Sahu, D., Lee, K., Lee, Y. S., Singh, P., Rajarathnam, K., & Iwahara, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.449942 · Cited by 89
HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA
Dormoy-Raclet, V., Cammas, A., Celona, B., Lian, X. J., van der Giessen, K., Zivojnovic, M., Brunelli, S., Riuzzi, F., Sorci, G., Wilhelm, B. T., et al. (2013) · Nature Communications · doi:10.1038/ncomms3388 · Cited by 89
Self-citationGuerriero, J. L., Ditsworth, D., Catanzaro, J. M., Sabino, G. J., Furie, M. B., Kew, R. R., Crawford, H. C., & Zong, W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003267 · Cited by 92
Gerlitz, G., Hock, R., Ueda, T., & Bustin, M. (2009) · Biochemistry and Cell Biology · doi:10.1139/o08-110 · Cited by 88
Jiang, R., Cai, J., Zhu, Z., Chen, D., Wang, J., Wang, Q., Teng, Y., Huang, Y., Tao, M., Aibin, X., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303445 · Cited by 86
High-Mobility Group Protein Box-1 and its Relevance to Cerebral Ischemia
Yang, Q., Wang, J., Li, J., Zhou, Y. J., Qizhong, Lu, F.-L., & Xiang, J. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.202 · Cited by 87
Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science
Antoine, D. J., Williams, D. P., & Park, B. K. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.11.1415 · Cited by 86
Ito, H., Fujita, K., Tagawa, K., Chen, X., Homma, H., Sasabe, T., Shimizu, J., Shimizu, S., Tamura, T., Muramatsu, S., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404392 · Cited by 89
HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism
Armando Rojas, R., Delgado‐López, F., Pérez-Castro, R., González, I., Romero, J. A., Rojas, I., Araya, P., Añazco, C. C., Morales, E., & Jorge Llanos, L. (2015) · Tumor Biology · doi:10.1007/s13277-015-3940-y · Cited by 83
Liu, Z., Falo, L. D., & You, Z. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003378 · Cited by 83
How Neutrophils Shape the Immune Response: Reassessing Their Multifaceted Role in Health and Disease
Shafqat, A., Khan, J. A., Alkachem, A. Y., Sabur, H., AlKattan, K. M., Yaqinuddin, A., & Sing, G. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417583 · Cited by 85
HMGB1 and its physiological and pathological roles
Naglova, H., & Bucová, M. (2012) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2012_039 · Cited by 82
Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas
Lee, H., Song, M., Shin, N., Shin, C. H., Min, B. S., Kim, H.-S., Yoo, J. S., & Kim, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034318 · Cited by 81
Ong, S. P., Lee, L. M., Leong, Y. F. I., Ng, M. L., & Chu, J. J. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041932 · Cited by 80
Ma, S., Ming, Z., Gong, A., Wang, Y., Chen, X., Hu, G., Zhou, R., Shibata, A., Swanson, P. C., & Chen, X. (2016) · The FASEB Journal · doi:10.1096/fj.201601056r · Cited by 82
Perioperative Inflammation and Its Modulation by Anesthetics
Rossaint, J., & Zarbock, A. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002484 · Cited by 80
A Network of HMG-box Transcription Factors Regulates Sexual Cycle in the Fungus Podospora anserina
Benkhali, J. A., Coppin, E., Brun, S., Peraza‐Reyes, L., Martin, T., Dixelius, C., Lazar, N., TILBEURGH, H. V., & Debuchy, R. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003642 · Cited by 77
Wang, X., Xiang, L., Li, H., Chen, P., Feng, Y., Zhang, J., Yang, N., Li, F., Wang, Y., Zhang, Q., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922527 · Cited by 76
Scarpa, M., Kessler, S. P., Sadler, T. M., West, G. A., Homer, C. R., McDonald, C., de la Motte, C., Fiocchi, C., & Stylianou, E. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.02.018 · Cited by 78
Redox State-Dependent Interaction of HMGB1 and Cisplatin-Modified DNA
Park, S., & Lippard, S. J. (2011) · Biochemistry · doi:10.1021/bi2000214 · Cited by 74
ROCK1 but not LIMK1 or PAK2 is a key regulator of apoptotic membrane blebbing and cell disassembly
Tixeira, R., Phan, T. K., Caruso, S., Shi, B., Atkin‐Smith, G. K., Nedeva, C., Chow, J. D. Y., Puthalakath, H., Hulett, M. D., Herold, M. J., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0342-5 · Cited by 77
High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy
Thakur, V., Sadanandan, J., & Chattopadhyay, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030881 · Cited by 74
HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9
Hirata, Y., Kurobe, H., Higashida, M., Fukuda, D., Shimabukuro, M., Tanaka, K., Higashikuni, Y., Kitagawa, T., & Sata, M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.09.010 · Cited by 73
Patterson, K. P., Brennan, G. P., Curran, M. M., Kinney‐Lang, E., Dubé, C. M., Rashid, F. M., Ly, C., Obenaus, A., & Baram, T. Z. (2015) · eNeuro · doi:10.1523/eneuro.0034-15.2015 · Cited by 73
Life after death: targeting high mobility group box 1 in emergent cancer therapies.
Guo, Z. S., Liu, Z., Bartlett, D. L., Tang, D., & Lotze, M. T. (2013) · Europe PMC (PubMed Central) · Cited by 72
Yang, R., Zou, X., Tenhunen, J. J., & Tønnessen, T. I. (2017) · Mediators of Inflammation · doi:10.1155/2017/5928078 · Cited by 72
Andrassy, M., Volz, H. C., Riedle, N., Gitsioudis, G., Seidel, C., Laohachewin, D., Zankl, A. R., Kaya, Z., Bierhaus, A., Giannitsis, E., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02369.x · Cited by 72
Brien, M., Baker, B., Duval, C., Gaudreault, V., Jones, R. L., & Girard, S. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0363 · Cited by 71
Frank, M. G., Adhikary, S., Sobesky, J. L., Weber, M. D., Watkins, L. R., & Maier, S. F. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.08.001 · Cited by 70
Riuzzi, F., Sorci, G., & Donato, R. (2011) · Journal of Cell Science · doi:10.1242/jcs.084491 · Cited by 70
Yang, J. M., Chen, L., Ding, J., Ding, J., Rong, H., Dong, W., & Li, X. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1106-6 · Cited by 68
Muhammad, A. K. M. G., Candolfi, M., King, G. D., Yagiz, K., Foulad, D. S., Mineharu, Y., Kroeger, K. M., Treuer, K. A., Nichols, W. S., Sanderson, N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1087 · Cited by 68
The perioperative immune response
O’Dwyer, M. J., Owen, H. C., & Torrance, H. D. T. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000213 · Cited by 68
sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells
Zhang, F., Su, X., Huang, G., Xin, X., Cao, E.-H., Shi, Y. P., & Song, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-14667-4 · Cited by 71
Preissner, K. T., Fischer, S., & Deindl, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.619221 · Cited by 67
Therapeutic Effects of Cold Atmospheric Plasma on Solid Tumor
Min, T., Xie, X., Ren, K., Sun, T., Wang, H., Dang, C., & Zhang, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.884887 · Cited by 75
Gámez-Díaz, L. Y., Enríquez, L. E., Matute, J. D., Velásquez, S., Gómez, I. D., Toro, F., Ospina, S., Bedoya, V. I., Arango, C., Valencia, M. L., et al. (2011) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2011.01113.x · Cited by 69
Wittwer, C., Boeck, S. H., Heinemann, V., Haas, M., Stieber, P., Nagel, D., & Holdenrieder, S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28294 · Cited by 66
Intracellular Nucleic Acid Sensors and Autoimmunity
Theofilopoulos, A. N., Kono, D. H., Beutler, B., & Baccalà, R. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0092 · Cited by 66
Bode, M. F., Haenel, D., Hagemeyer, C. E., Seeba, H., Duerschmied, D., Bassler, N., Jandeleit-Dahm, K. A. M., Sweet, M. J., Agrotis, A., Bobik, A., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-12-1073 · Cited by 65
Melki, M., Saïdi, H., Dufour, A., Olivo‐Marín, J., & Gougeon, M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000862 · Cited by 65
Nucleic acid-associated autoantigens: Pathogenic involvement and therapeutic potential
Hoffmann, M. H., Trembleau, S., Muller, S., & Steiner, G. E. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.013 · Cited by 66
The confluence of radiotherapy and immunotherapy
Burnette, B., Fu, Y., & Weichselbaum, R. R. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00143 · Cited by 65
Robinson, A. P., Caldis, M. W., Harp, C. T., Goings, G. E., & Miller, S. D. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.02.005 · Cited by 64
Huang, J., Liu, B., Yang, C., Chen, H., Eunice, D., & Yuan, Z. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.057 · Cited by 66
Translational Systems Biology of Inflammation: Potential Applications to Personalized Medicine
Mi, Q., Li‐Jessen, N. Y. K., Ziraldo, C., Ghuma, A., Mikheev, M., Squires, R. H., Okonkwo, D. O., Verdolini-Abbott, K., Constantine, G. M., An, G. C., et al. (2010) · Personalized Medicine · doi:10.2217/pme.10.45 · Cited by 65
Long, H., Chen, C., Zhang, J., & Sun, L. (2014) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2014.01.013 · Cited by 63
Taverna, S., Tonacci, A., Ferraro, M., Cammarata, G., Cuttitta, G., Bucchieri, S., Pace, E., & Gangemi, S. (2022) · Cells · doi:10.3390/cells11050849 · Cited by 64
High mobility group B1 impairs hepatocyte regeneration in acetaminophen hepatotoxicity
Yang, R., Zhang, S., Cotoia, A., Oksala, N., Zhu, S., & Tenhunen, J. J. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-45 · Cited by 63
Elsheikh, A., Lavergne, S. N., Castrejón-Flores, J. L., Farrell, J., Wang, H., Sathish, J. G., Pichler, W. J., Park, B. K., & Naisbitt, D. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000889 · Cited by 66
Dangerous connections: neutrophils and the phagocytic clearance of activated platelets
Manfredi, A. A., Rovere, P. Q., & Maugeri, N. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283324f97 · Cited by 62
Self-citationZhou, M., Wen, Z., Cheng, F., Ma, J., Li, W., Ren, H., Sheng, Y., Dong, H., Lu, L., Hu, H., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1180485 · Cited by 65
Watanabe, H. (2018) · Journal of Immunology Research · doi:10.1155/2018/5163129 · Cited by 64
Systemic toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease
McDonnell, M. E., Liang, Y., Noronha, A. M., Coukos, J. A., Kasper, D. L., Farraye, F. A., & Ganley-Leal, L. M. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21424 · Cited by 60
Activated macrophages in the tumour microenvironment—dancing to the tune of TLR and NF‐κB
Hallam, S. L., Escorcio‐Correia, M., Soper, R., Schultheiss, A., & Hagemann, T. (2009) · The Journal of Pathology · doi:10.1002/path.2602 · Cited by 62
Intraocular expression and release of high-mobility group box 1 protein in retinal detachment
Arimura, N., Kii, Y., Hashiguchi, T., Kawahara, K., Biswas, K. K., Nakamura, M., Sonoda, Y., Yamakiri, K., Okubo, A., Sakamoto, T., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2008.165 · Cited by 58
Riuzzi, F., Sorci, G., Beccafico, S., & Donato, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028700 · Cited by 60
Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis
Urbonaviciute, V., Meister, S., Fürnrohr, B. G., Frey, B., Gückel, E., Schett, G. A., i, M. H., & Voll, R. E. (2009) · Autoimmunity · doi:10.1080/08916930902831803 · Cited by 57
Comite, G. D., Rossi, C. M., Marinosci, A., Lolmède, K., Baldissera, E. M., Aiello, P., Müeller, R. B., i, M. H., Voll, R. E., Rovere, P. Q., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0608358 · Cited by 57
Self-citationDoes major surgery induce immune suppression and increase the risk of postoperative infection?
Torrance, H. D. T., Pearse, R. M., & O’Dwyer, M. J. (2016) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000331 · Cited by 57
Alarmins and Antitumor Immunity
Nie, Y., Yang, D., & Oppenheim, J. J. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.021 · Cited by 57
Local Inflammation in Fracture Hematoma: Results from a Combined Trauma Model in Pigs
Horst, K., Eschbach, D. A., Pfeifer, R., Hübenthal, S., Sassen, M. C., Steinfeldt, T., Wulf, H., Ruchholtz, S., Pape, H., & Hildebrand, F. (2015) · Mediators of Inflammation · doi:10.1155/2015/126060 · Cited by 56
Ebina, M., Taniguchi, H., Miyasho, T., Yamada, S., Shibata, N., Ohta, H., Hisata, S., Ohkouchi, S., Tamada, T., Nishimura, H., et al. (2011) · Pulmonary Medicine · doi:10.1155/2011/916486 · Cited by 56
Zhu, X., Chen, J., Zhou, F., Liu, Q., Chen, G., & Zhang, J. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-194 · Cited by 56
Metadata
- Authors
- Bianchi, M. E., & Manfredi, A. A.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Corresponding author
- Bianchi, Marco E.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2007-10-30
- Volume
- 220
- Issue
- 1
- Pages
- 35-46
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2109590683
- Cited by
- 600
- References
- 86
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 13 · 2023: 20 · 2022: 28 · 2021: 21 · 2020: 17 · 2019: 25 · 2018: 41 · 2017: 34 · 2016: 26 · 2015: 37 · 2014: 44 · 2013: 55 · 2012: 45
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Immunological Reviews (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- HMGB1, high mobility group box 1, innate immunity, adaptive immunity, inflammation, tissue repair, dendritic cell maturation, T cell activation, autoimmunity, necrosis, chemokines, stem cell recruitment, autocrine and paracrine signaling
- MeSH terms
- Animals, Dendritic Cells, Humans, Immunity, Innate, Lupus Erythematosus, Systemic, T-Lymphocytes, Autoimmunity, Sepsis, HMGB1 Protein, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
